LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

<
<<
Previous
Page 1 of 535
Next
>>
>
1 to 25 of 13356 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Normalized Growth Rate Inhibition Value
BT-20	Sorafenib	0.04	uM	LJP6	1	B12	72	hr	1097	3425	3610	0.9486	0.9395
BT-20	Sorafenib	3.33	uM	LJP6	1	B08	72	hr	1097	3211	3610	0.8893	0.8681
BT-20	AZD8055	0.37	uM	LJP6	1	A10	72	hr	1097	1109	3610	0.3072	0.0062
BT-20	AZD8055	10	uM	LJP6	1	A07	72	hr	1097	125	3610	0.0346	-0.7175
BT-20	Sorafenib	0.37	uM	LJP6	1	B10	72	hr	1097	3202	3610	0.8868	0.8650
BT-20	Sorafenib	1.11	uM	LJP6	1	B09	72	hr	1097	3050	3610	0.8447	0.8130
BT-20	AZD8055	0.04	uM	LJP6	1	A12	72	hr	1097	1365	3610	0.3781	0.1355
BT-20	AZD8055	0.12	uM	LJP6	1	A11	72	hr	1097	1307	3610	0.3620	0.1072
BT-20	AZD7762	1.11	uM	LJP6	1	L03	72	hr	1097	1334	3610	0.3695	0.1204
BT-20	AZD8055	3.33	uM	LJP6	1	A08	72	hr	1097	880	3610	0.2437	-0.1205
BT-20	Sorafenib	0.12	uM	LJP6	1	B11	72	hr	1097	3657	3610	1.0129	1.0149
BT-20	AZD7762	10	uM	LJP6	1	L01	72	hr	1097	422	3610	0.1169	-0.4266
BT-20	AT-7519	3.33	uM	LJP6	1	K02	72	hr	1097	445	3610	0.1233	-0.4086
BT-20	AT-7519	10	uM	LJP6	1	K01	72	hr	1097	578	3610	0.1601	-0.3114
BT-20	AT-7519	0.04	uM	LJP6	1	K06	72	hr	1097	3009	3610	0.8334	0.7987
BT-20	AZD7762	3.33	uM	LJP6	1	L02	72	hr	1097	714	3610	0.1978	-0.2213
BT-20	AZD7762	0.04	uM	LJP6	1	L06	72	hr	1097	3505	3610	0.9708	0.9658
BT-20	AZD7762	0.12	uM	LJP6	1	L05	72	hr	1097	2554	3610	0.7074	0.6350
BT-20	AT-7519	0.12	uM	LJP6	1	K05	72	hr	1097	1761	3610	0.4877	0.3169
BT-20	AZD7762	0.37	uM	LJP6	1	L04	72	hr	1097	2004	3610	0.5550	0.4198
BT-20	AT-7519	0.37	uM	LJP6	1	K04	72	hr	1097	710	3610	0.1966	-0.2238
BT-20	AZD8055	1.11	uM	LJP6	1	A09	72	hr	1097	1019	3610	0.2822	-0.0421
BT-20	AT-7519	1.11	uM	LJP6	1	K03	72	hr	1097	522	3610	0.1446	-0.3510
BT-20	Alvocidib	0.04	uM	LJP6	1	A18	72	hr	1097	1142	3610	0.3163	0.0235
BT-20	Sorafenib	10	uM	LJP6	1	B07	72	hr	1097	1236	3610	0.3423	0.0718

<
<<
Previous
Page 1 of 535
Next
>>
>
1 to 25 of 13356 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)